Title for MeetingAbstracts
Alphabetical listing of titles
Claims against culture: vulnerability, law and a rights-based approach to HIV in Egypt.
Clarithromycin (CL) plus rifabutin (RFB) for MAC prophylaxis: evidence for a drug interaction.
Clarithromycin (CL) plus rifabutin (RTB) for MAC prophylaxis: tolerability of the combination.
Clarithromycin (CLA) for the prevention of Mycobacterium avium complex (MAC) in AIDS.
Clarithromycin (CLA) Resistance in H. pylori (Hp) Is Caused by Specific Mutations Localized in the 23S rRNA Gene.
Clarithromycin (CLR) does not affect intracellular concentrations of phosphorylated metabolites of zidovudine (ZDV).
Clarithromycin + minocycline as a treatment for cerebral toxoplasmosis (CT) in HIV-infected patients (PTS).
Clarithromycin 500 mg BID as primary prophylaxis for dMAC disease.
Clarithromycin 500 mg bid for dMAC prophylaxis.
Clarithromycin 500mg bid as primary prophylaxis in patients with AIDS.
Clarithromycin 500mg bid for MAC prophylaxis in patients with AIDS.
Clarithromycin and zidovudine pharmacokinetic study.
Clarithromycin as primary prophylaxis in patients with AIDS.
Clarithromycin for disseminated Mycobacterium avium-complex in AIDS patients.
Clarithromycin for mycobacterium avium complex prophylaxis in patients with AIDS.
Clarithromycin for the prevention of M. avium complex in AIDS.
Clarithromycin in 100 AIDS patients with disseminated M avium infection. Clarithromycin Trial Group.
Clarithromycin in 500 mg BID as prophylaxis for MAC disease--a restrospective study.
Clarithromycin monotherapy in AIDS patients with MAI: efficacy and resistance.
Clarithromycin prophylaxis against MAC in AIDS.
Clarithromycin prophylaxis for MAC in AIDS patients reduces the incidence of treatment-emergent respiratory tract infections.
Clarithromycin susceptibilities and genetic patterns of mycobacterium avium complex (MAC) isolates of AIDS patients at autopsy.
Clarithromycin Therapy for Bacillus anthracis Infection in [60]Co Gamma-Irradiated and Non-Irradiated Mice.
Clarithromycin therapy of disseminated MAC infection.
Clarithromycin-based combination therapy for Mycobacterium Avium-intracellulare complex (MAC) lymphadenitis in children.
Clarithromycin-minocyclin (cla-mino) combination as salvage therapy for toxoplasmosis (TX) in 8 AIDS patients (pts).
Clarithromycin-resistant Mycobacterium avium (CLA-R) is virulent in mice and is susceptible to treatment with clarithromycin.
Clarithromycin-resistant Mycobacterium avium (MAC) strain in a clarithromycin naive AIDS patient.
Clarithromycin: safe and effective prophylactic agent against MAC.
Clash of Two HIV-1 Epidemics in Guangxi, China.